Pseudoangiomatous stromal hyperplasia

From WikiMD's WELLNESSPEDIA

Pseudoangiomatous stromal hyperplasia
Pseudoangiomatous stromal hyperplasia - high mag.jpg
High magnification micrograph of pseudoangiomatous stromal hyperplasia showing the characteristic small, anastomosing blood vessel-like channels. H&E stain.



Specialty Pathology
















Pseudoangiomatous stromal hyperplasia (PASH), is an overgrowth of myofibroblastic cells in the breast. It has an appearance similar to fibroadenomatoid changes.[1]

The diagnostic significance is currently uncertain, but it appears to be benign. There have been cases of PASH diagnosed where the tumors co-exist with breast cancer. Other cases have made screening for breast cancer difficult and in some cases impossible due to the number and density of the existing PASH tumors. These cases have resulted in the necessity of a mastectomy and double mastectomy.

Diagnosis[edit]

Intermediate magnification micrograph showing the relative abundance of stroma in a case of PASH. H&E stain.

The diagnosis of PASH is by biopsy.

The important differential diagnosis is angiosarcoma, from which it was first differentiated in 1986.[2]

Differential diagnosis[edit]

Treatment[edit]

The management of PASH is controversial. Excision may be indicated in enlarging masses or lesions with atypical features.

References[edit]

  1. "Pseudoangiomatous stromal hyperplasia (PASH). A mammary stromal tumor with myofibroblastic differentiation".Am. J. Surg. Pathol..March 1995;19(3)
    270–7.doi:10.1097/00000478-199503000-00004.PMID:7872425.
  2. "Pseudoangiomatous hyperplasia of mammary stroma".Hum. Pathol..February 1986;17(2)
    185–91.doi:10.1016/S0046-8177(86)80292-1.PMID:3949338.
  3. "Pseudoangiomatous hyperplasia of mammary stroma in an HIV patient".Gen Diagn Pathol.December 1997;143(4)
    251–4.PMID:9489960.

External links[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.